Bone Marrow Transplantation: What Is the Question?
Excerpt
Allogeneic bone marrow transplantation is entering its third decade as a curative therapeutic modality for treating certain malignant and nonmalignant diseases. Some controversies still surround its use. One controversy pertains to the proper timing of marrow transplantation for the acute leukemias, specifically for acute lymphoblastic leukemia in the adult patient. The appropriate time to proceed to marrow transplantation depends on the stage of the disease.
The use of modern combination chemotherapy in adults who have a relapse after their first remission is associated with a dismal prognosis; there are only a few anecdotal case reports of long-term, disease-free survival. In
This 100-word excerpt has been provided in the absence of an abstract.
Article and Author Information
-
Requests for Reprints: Nelson J. Chao, MD, Bone Marrow Transplantation Program, Room H-1353, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305
Most Read
